HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Judith S Currier Selected Research

octane

10/2019Linked dual-class HIV resistance mutations are associated with treatment failure.
4/2012Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women.
1/2012The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Judith S Currier Research Topics

Disease

37HIV Infections (HIV Infection)
01/2022 - 05/2003
30Acquired Immunodeficiency Syndrome (AIDS)
10/2020 - 04/2002
29Cardiovascular Diseases (Cardiovascular Disease)
10/2022 - 03/2004
16Infections
11/2021 - 07/2002
15Inflammation (Inflammations)
12/2021 - 02/2011
12Atherosclerosis
10/2022 - 06/2005
9Opportunistic Infections (Opportunistic Infection)
11/2014 - 04/2002
7COVID-19
12/2022 - 01/2021
7Viremia
01/2021 - 03/2008
5Insulin Resistance
01/2022 - 11/2010
5Dyslipidemias (Dyslipidemia)
09/2014 - 09/2003
4Disease Progression
12/2021 - 06/2011
4Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2021 - 08/2005
4Tuberculosis (Tuberculoses)
07/2015 - 03/2005
3Hypertension (High Blood Pressure)
12/2021 - 08/2016
3Myocardial Infarction
10/2020 - 04/2008
3Hepatitis
05/2014 - 04/2012
3Exanthema (Rash)
07/2012 - 11/2008
2Infant Death
01/2022 - 11/2016
2Obesity
12/2021 - 05/2017
2Weight Gain
01/2021 - 01/2020
2Pregnancy Complications
01/2021 - 01/2018
2Heart Failure
01/2020 - 01/2019
2Fibrosis (Cirrhosis)
01/2018 - 12/2017
2Bone Diseases (Bone Disease)
01/2018 - 07/2014
2Hyperbilirubinemia
09/2015 - 10/2014
2Coinfection
12/2014 - 05/2011
2Atherosclerotic Plaque (Atheroma)
01/2014 - 03/2008
2Vitamin D Deficiency
04/2013 - 06/2012
2Virus Diseases (Viral Diseases)
04/2013 - 03/2005
2Diarrhea
07/2012 - 10/2010
2Lipodystrophy
06/2012 - 05/2011
2Malaria
02/2012 - 01/2012
2Lactic Acidosis
07/2007 - 03/2007
2Hypersensitivity (Allergy)
03/2007 - 12/2003
1Heart Diseases (Heart Disease)
01/2022
1Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2019

Drug/Important Bio-Agent (IBA)

14LipidsIBA
01/2022 - 03/2004
13Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2012
9Ritonavir (Norvir)FDA Link
02/2019 - 01/2012
7RNA (Ribonucleic Acid)IBA
12/2021 - 04/2002
7Tenofovir (Viread)FDA Link
10/2019 - 06/2015
6Antiviral Agents (Antivirals)IBA
12/2021 - 05/2011
6Pharmaceutical PreparationsIBA
01/2021 - 06/2011
6Emtricitabine (Emtriva)FDA Link
10/2019 - 06/2015
6Raltegravir PotassiumFDA Link
02/2019 - 01/2014
6Atazanavir Sulfate (Reyataz)FDA Link
02/2019 - 10/2014
5VaccinesIBA
12/2021 - 12/2003
5C-Reactive ProteinIBA
12/2021 - 07/2015
5HDL LipoproteinsIBA
01/2021 - 01/2014
5Nevirapine (Viramune)FDA Link
10/2019 - 11/2008
5Darunavir (Prezista)FDA Link
02/2019 - 07/2012
5Protease Inhibitors (Protease Inhibitor)IBA
11/2016 - 06/2005
4AntigensIBA
12/2021 - 12/2003
4Lipopolysaccharide ReceptorsIBA
12/2021 - 11/2012
4Integrase InhibitorsIBA
12/2021 - 08/2015
4Interleukin-6 (Interleukin 6)IBA
12/2021 - 03/2013
4Glucose (Dextrose)FDA LinkGeneric
12/2021 - 11/2002
3Monoclonal AntibodiesIBA
01/2022 - 12/2021
3AdiponectinIBA
10/2021 - 01/2014
3Methotrexate (Mexate)FDA LinkGeneric
12/2020 - 12/2018
3octaneIBA
10/2019 - 01/2012
3AntioxidantsIBA
06/2018 - 02/2011
3OsteoprotegerinIBA
01/2018 - 06/2013
3LopinavirFDA Link
01/2018 - 01/2012
3Lamivudine (Epivir)FDA Link
01/2018 - 11/2008
3Lipoproteins (Lipoprotein)IBA
01/2017 - 09/2015
3Vitamin DFDA LinkGeneric
03/2016 - 04/2015
2RacivirIBA
01/2022 - 01/2018
2bamlanivimabIBA
12/2021 - 09/2021
2LDL CholesterolIBA
12/2021 - 01/2019
2LeptinIBA
10/2021 - 01/2021
2Advanced Glycation End ProductsIBA
10/2021 - 06/2018
2Triglycerides (Triacylglycerol)IBA
01/2021 - 01/2020
2HDL CholesterolIBA
01/2021 - 09/2015
2Telmisartan (Micardis)FDA Link
01/2018 - 01/2013
2Zidovudine (Retrovir)FDA LinkGeneric
01/2018 - 11/2016
2RANK LigandIBA
01/2018 - 07/2014
2Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2017 - 02/2011
2Indicators and Reagents (Reagents)IBA
01/2017 - 03/2013
2fibrin fragment D (D-dimer)IBA
11/2016 - 08/2015
2DNA (Deoxyribonucleic Acid)IBA
10/2015 - 03/2009
2BilirubinIBA
09/2015 - 09/2015
2Proteins (Proteins, Gene)FDA Link
09/2014 - 01/2012
2CalciumIBA
05/2014 - 08/2008
2Stavudine (Zerit)FDA LinkGeneric
11/2008 - 07/2007
1cilgavimab and tixagevimab drug combinationIBA
12/2022
1cilgavimabIBA
12/2022
1tixagevimabIBA
12/2022
1Nucleic AcidsIBA
12/2021
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
10/2021
1Alanine Transaminase (SGPT)IBA
01/2021
1Antihypertensive Agents (Antihypertensives)IBA
01/2021
1lipopolysaccharide-binding proteinIBA
10/2020
1Aligeron (AS 2)IBA
01/2020
1cabotegravirIBA
01/2020
1Illicit Drugs (Recreational Drugs)IBA
02/2019

Therapy/Procedure

58Therapeutics
10/2022 - 04/2002
26Art Therapy
10/2022 - 12/2008
6Highly Active Antiretroviral Therapy (HAART)
01/2016 - 04/2002